green
Positive treatment
6.9 score
Treatment trajectory · 2002 → 2026 · click a year to view as-of
2002
2014
2026
Top citers, strongest first. 11 distinct citers.
How cited ↗
discussed
Cited "see"
In Re Sepracor, Inc. Securities Litigation
(2×)
See Helwig v. Vencor, Inc., 251 F.3d 540, 557 (6th Cir.2001), cert. denied, 536 U.S. 935 , 122 S.Ct. 2616 , 153 L.Ed.2d 800 (2002); Rubinstein v. Collins, 20 F.3d 160, 166 (5th Cir.1994); In re Wells Fargo Sec.
cited
Cited "see"
Larsen v. Cigna Healthcare Mid-Atlantic, Inc.
See, Corporate Health Ins., Inc. v. Texas Dept. of Ins., 215 F.3d 526 (5th Cir.2000), vacated and remanded by, — U.S. -, 122 S.Ct. 2617 , 153 L.Ed.2d 800 (2002).
discussed
Cited "see"
Daniel Chen v. Navarre Corporation
(2×)
See Helwig v. Vencor, Inc., 251 F.3d 540, 552 (6th Cir.2001) (setting forth nine factors usually relevant to scienter), cert. dismissed, - U.S. -, 122 S.Ct. 2616 , 153 L.Ed.2d 800 (2002); Greebel, 194 F.3d at 196-98 (same).
discussed
Cited "see"
In RE: NAVARRE CORPORATION SECURITIES LITIGATION DANIEL CHEN, ON BEHALF OF HIMSELF AND ALL OTHERS SIMILARLY SITUATED, — JUDY POUCHER, ON BEHALF OF HERSELF AND ALL OTHERS SIMILARLY SITUATED, ADVANCED DATA CONCEPTS STEVE CHAHINE LEE TACHMAN v. NAVARRE CORP. ERIC H. PAULSON CHARLES E. CHENEY ALFRED TEO DICKINSON G. WILTZ JAMES G. SIPPL MICHAEL L. SNOW, —
(2×)
See Helwig v. Vencor, Inc., 251 F.3d 540, 552 (6th Cir.2001) (setting forth nine factors usually relevant to scienter), cert. dismissed, ___ U.S. ___, 122 S.Ct. 2616 , 153 L.Ed.2d 800 (2002); Greebel, 194 F.3d at 196-98 (same);.
discussed
Cited "see"
Chen v. Navarre Corp.
(2×)
See Helwig v. Vencor, Inc., 251 F.3d 540, 552 (6th Cir.2001) (setting forth nine factors usually relevant to scienter), cert. dismissed, — U.S. -, 122 S.Ct. 2616 , 153 L.Ed.2d 800 (2002); Greebel, 194 F.3d at 196-98 (same);.
discussed
Cited "see"
In re Navarre Corp. Securities Litigation
(2×)
See Helwig v. Vencor, Inc., 251 F.3d 540, 552 (6th Cir.2001) (setting forth nine factors usually relevant to scienter), cert. dismissed, ___ U.S. ___, 122 S.Ct. 2616 , 153 L.Ed.2d 800 (2002); Greebel, 194 F.3d at 196-98 (same).
discussed
Cited "see, e.g."
Ansfield v. Omnicare, Inc. (In Re Omicare, Inc. Securities Litigation)
KBC claims that “this [c]ourt may consider ‘not only those documents referenced in the plaintiffs’ complaint, but also documents filed with the SEC.’ ” Appellant MJN at 5 (quoting Helwig v. Vencor, 210 F.3d 612 , 618 n. 10 (6th Cir.2000), rev’d on other grounds, 251 F.3d 540 (6th Cir.2001) (en banc), cert. denied, 536 U.S. 935 , 122 S.Ct. 2616 , 153 L.Ed.2d 800 (2002)); see also id. at 5 n. 2 (citing, inter alia, Kramer v. Time Warner, Inc., 937 F.2d 767, 774 (2d Cir.1991)).
discussed
Cited "see, e.g."
Blue Cross And Blue Shield Of Illinois v. Julia Cruz
As noted by the Ninth Circuit, "[t]he new provision closely resembles ERISA's express preemption provision, and precedent interpreting the ERISA provision thus provides authority for cases involving the FEHBA provision." Botsford, 314 F.3d at 393-94 ; see also Corporate Health Ins., Inc. v. Tex. Dep't of Ins., 215 F.3d 526, 539 (5th Cir.2000), vacated on other grounds, 536 U.S. 935 , 122 S.Ct. 2617 , 153 L.Ed.2d 800 (2002).
discussed
Cited "see, e.g."
Blue Cross & Blue Shield of Illinois v. Cruz
As noted by the Ninth Circuit, "[t]he new provision closely resembles ERISA’s express preemption provision, and precedent interpreting the ERISA, provision thus provides authority for cases involving the FEHBA provision.” Botsford, 314 F.3d at 393-94 ; see also Corporate Health Ins., Inc. v. Tex. Dep't of Ins., 215 F.3d 526, 539 (5th Cir.2000), vacated on other grounds, 536 U.S. 935 , 122 S.Ct. 2617 , 153 L.Ed.2d 800 (2002).
discussed
Cited "see, e.g."
Gompper v. Visx, Inc.
(2×)
See also Helwig v. Vencor, Inc., 251 F.3d 540, 553 (6th Cir.2001) (en banc), cert. dismissed, - U.S.-, 122 S.Ct. 2616 , 153 L.Ed.2d 800 (2002) (PSLRA’s strong inference requirement “means that plaintiffs are entitled only to the most plausible of competing inferences.”).
discussed
Cited "see, e.g."
Gompper v. Visx
(2×)
See also Helwig v. Vencor, Inc., 251 F.3d 540, 553 (6th Cir.2001) (en banc), cert. dismissed, ___ U.S. ___, 122 S.Ct. 2616 , 153 L.Ed.2d 800 (2002) (PSLRA's strong inference requirement "means that plaintiffs are entitled only to the most plausible of competing inferences.").
Retrieving the full opinion text from the archive…
Vencor, Inc., Et Al.
v.
Helwig Et Al.
v.
Helwig Et Al.
01-538.
Supreme Court of the United States.
Jun 20, 2002.
Published
C. A. 6th Cir. Certiorari dismissed under this Court’s Rule 46.1.